Bioqual, Inc. (BIOQ)
OTCMKTS · Delayed Price · Currency is USD
33.00
0.00 (0.00%)
At close: Aug 31, 2026

Bioqual Income Statement

Millions USD. Fiscal year is Jun - May.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
39.9548.8758.5962.6666.15
Revenue Growth
-18.25%-16.59%-6.50%-5.27%14.68%
Cost of Revenue
43.6639.7346.5550.0649.2
Gross Profit
-3.729.1412.0512.616.95
Selling, General & Admin
-11.0312.0611.510.42
Operating Expenses
-11.0312.0611.510.42
Operating Income
-3.72-1.9-0.021.16.53
Interest & Investment Income
-0.610.480.030
Other Non Operating Income (Expenses)
-00.0200.04
EBT Excluding Unusual Items
-3.72-1.290.481.136.58
Pretax Income
-3.72-1.290.481.136.58
Income Tax Expense
0.45-0.24-0.010.31.32
Net Income
-4.17-1.050.480.845.26
Net Income to Common
-4.17-1.050.480.845.26
Net Income Growth
---42.14%-84.12%-16.85%
Shares Outstanding (Basic)
11111
Shares Outstanding (Diluted)
11111
Shares Change
----0.00%0.04%
EPS (Basic)
-4.66-1.170.540.935.88
EPS (Diluted)
-4.66-1.170.540.935.88
EPS Growth
---41.94%-84.18%-16.91%

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Free Cash Flow
-2.718.765.99-4.57
Free Cash Flow Per Share
-3.039.806.69-5.11
Dividend Per Share
-0.5000.5000.5001.000
Dividend Growth
-0%0%-50.00%-20.00%
Gross Margin
-9.30%18.70%20.56%20.11%25.62%
Operating Margin
-9.30%-3.88%-0.03%1.76%9.88%
Profit Margin
-10.44%-2.15%0.83%1.33%7.95%
Free Cash Flow Margin
-5.54%14.95%9.55%-6.91%
EBITDA
-1.470.472.543.388.25
EBITDA Margin
-3.69%0.97%4.33%5.39%12.46%
D&A For EBITDA
2.242.372.562.281.71
EBIT
-3.72-1.9-0.021.16.53
EBIT Margin
-9.30%-3.88%-0.03%1.76%9.88%
Effective Tax Rate
---26.27%20.01%